<DOC>
	<DOCNO>NCT02233387</DOCNO>
	<brief_summary>The aim study : 1. determine tumor hypoxia accurately visualise [ 18F ] HX4 PET image cervix cancer , 2. correlate [ 18F ] HX4 PET image blood tissue marker , 3. investigate quality optimal timing [ 18F ] HX4 PET image , 4. compare [ 18F ] HX4 PET uptake [ 18F ] FDG PET uptake treatment 5. analyze correlation response</brief_summary>
	<brief_title>PET CT With HX4 Cervix Cancer</brief_title>
	<detailed_description>Tumor hypoxia situation tumor cell deprive oxygen . Hypoxic tumor cell usually resistant radiotherapy chemotherapy likely develop metastasis . In Cervix cancer , tumor hypoxia know important prognostic factor long term survival . [ 18F ] HX4 develop diagnostic radiopharmaceutical PET image find marker hypoxia use standard clinical practice . Current hypoxia tracer lack reliable image quality kinetics . Because short half life clearance , investigator expect [ 18F ] HX4 high tumor background ratio current nitro-imidazole hypoxia marker [ 18F ] -misonidazole . In recent phase 1 clinical study van Loon et al , PET-imaging [ 18F ] HX4 feasible without toxicity . The clinical use reliable , non-invasive easy use hypoxia image agent could allow selection patient likely benefit hypoxia modify therapy .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Inclusion criterion Histologically confirm cervix carcinoma ( squamous cell carcinoma , adenocarcinoma adenosquamous carcinoma ) tumor stage FIGO IB IVA WHO performance status 0 2 Scheduled primary curative radiotherapy ( either combine chemotherapy hyperthermia ) No previous surgery Cervix No previous radiation Cervix The patient willing capable comply study procedures 18 year old Written inform consent patient registration Exclusion criterion Recent ( &lt; 3 month ) myocardial infarction Uncontrolled infectious disease Pregnant breast feed and/or willing take adequate contraceptive measure study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>cervix cancer</keyword>
	<keyword>[ 18F ] HX4 PET image</keyword>
	<keyword>hypoxia</keyword>
	<keyword>phase II trial</keyword>
</DOC>